Iota-carrageenan prevents the replication of SARS-CoV-2 on an in vitro respiratory epithelium model

Varese et al., bioRxiv, doi:10.1101/2021.04.27.441512

Apr 2021

Source PDF All Studies Meta AnalysisMeta

In Vitro Calu-3 (human respiratory epithelial cell line) study showing that iota-carrageenan inhibits SARS-CoV-2.

15 preclinical studies support the efficacy of iota-carrageenan for COVID-19:

4 In Silico studies Alsaidi, Rohilla, Sattari, Thet

11 In Vitro studies Alsaidi, Bansal, Bovard, Fröba, Meister, Morokutti-Kurz, Morokutti-Kurz (B), Setz, Song, Varese, Yathindranath

Important missing comments or errors? Let us know.

1. Alsaidi et al., Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model, Marine Drugs, doi:10.3390/md19080418.mdpi.com, doi.org.

2. Bansal et al., Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture, PLoS ONE, doi:10.1371/journal.pone.0259943.plos.org, doi.org.

3. Bovard et al., Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia, Biochemistry and Biophysics Reports, doi:10.1016/j.bbrep.2021.101187.sciencedirect.com, doi.org.

4. Fröba et al., Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta, International Journal of Molecular Sciences, doi:10.3390/ijms222413202.mdpi.com, doi.org.

5. Meister et al., Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2, Journal of Hospital Infection, doi:10.1016/j.jhin.2021.10.019.sciencedirect.com, doi.org.

6. Morokutti-Kurz et al., Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro, PLoS ONE, doi:10.1371/journal.pone.0237480.plos.org, doi.org.

7. Morokutti-Kurz (B) et al., Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat, International Journal of General Medicine, doi:10.2147/IJGM.S120665.dovepress.com, doi.org.

8. Rohilla et al., Algae Polysaccharides (Carrageenan and Alginate)—A Treasure-Trove of Antiviral Compounds: An In Silico Approach to Identify Potential Candidates for Inhibition of S1-RBD Spike Protein of SARS-CoV-2, Stresses, doi:10.3390/stresses3030039.mdpi.com, doi.org.

9. Sattari et al., Repositioning Therapeutics for COVID-19: Virtual Screening of the Potent Synthetic and Natural Compounds as SARS-CoV-2 3CLpro Inhibitors, Research Square, doi:10.21203/rs.3.rs-37994/v1.researchsquare.com, doi.org.

10. Setz et al., Iota-Carrageenan Inhibits Replication of the SARS-CoV-2 Variants of Concern Omicron BA.1, BA.2 and BA.5, Nutraceuticals, doi:10.3390/nutraceuticals3030025.mdpi.com, doi.org.

11. Song et al., Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2, Food & Function, doi:10.1039/D0FO02017F.rsc.org, doi.org.

12. Thet, H., The potential of carrageenan for the drug discovery of COVID-19 via molecular docking with angiotensin-converting enzyme 2 (ACE2) and the main protease (Mpro) of SARS-CoV-2, Journal of Bioinformatics and Genomics, doi:10.18454/jbg.2022.18.2.001.journal-biogen.org, doi.org.

13. Varese et al., Iota-carrageenan prevents the replication of SARS-CoV-2 on an in vitro respiratory epithelium model, bioRxiv, doi:10.1101/2021.04.27.441512.biorxiv.org, doi.org.

14. Yathindranath et al., Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection, International Journal of Nanomedicine, doi:10.2147/IJN.S448005.dovepress.com, doi.org.

Varese et al., 27 Apr 2021, preprint, 5 authors.

In Vitro studies are an important part of preclinical research, however results may be very different in vivo.

This Paper Iota-carragee..All

Iota-carrageenan prevents the replication of SARS-CoV-2 on an in vitro respiratory epithelium model

Augusto Varese, Ana Ceballos, Carlos Palacios, Juan Manuel Figueroa, Andrea Vanesa Dugour

doi:10.1101/2021.04.27.441512

There are, except for remdesivir, no approved antivirals for the treatment or prevention of SARS-CoV-2 infections. Iota-carrageenan formulated into a nasal spray has already been proven safe and effective in viral respiratory infections. We explored this antiviral activity in Calu-3, a human respiratory model cell line. A formula of iota-carrageenan and sodium chloride, as a nasal spray, already approved for human use, effectively inhibited SARS-CoV-2 infection in vitro, providing a more substantial reference for further clinical studies or developments.

Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Author Contributions AC, AVD, and JMF conceptualized the study. AC, AV, CP and AVD developed the methodology. JMF wrote and prepared the original draft. AC, AVD, and CP wrote, reviewed, and edited the manuscript. AC and AVD supervised the study. All authors contributed to the article and approved the submitted version.

References

Banerjee, Nasir, Budylowski, Yip, Aftanas et al., Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2, Emerg Infect Dis, doi:10.3201/eid2609.201495

Bansal, Jonsson, Taylor, Figueroa, Dugour et al., Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture, Biorxiv, doi:10.1101/2020.08.19.225854

Barrett, Terpening, Snow, Cobb, Kistner, Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases, Expert Rev Vaccines, doi:10.1080/14760584.2017.1357471

Chen, Han, Wang, Zhao, Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines, Int J Biol Macromol, doi:10.1016/j.ijbiomac.2020.07.106

Dong, Du, Gardner, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, doi:10.1016/s1473-3099(20)30120-1

Duszyk, CFTR and lysozyme secretion in human airway epithelial cells, Pflügers Archiv, doi:10.1007/s004240100643

Felgenhauer, Schoen, Gad, Hartmann, Schaubmar et al., Inhibition of SARS-CoV-2 by type I and type III interferons, J Biol Chem, doi:10.1074/jbc.ac120.013788

Figueroa, Lombardo, Dogliotti, Flynn, Giugliano et al., Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease A pragmatic multicenter, randomized, double-blind, placebo-controlled trial, CARR-COV, doi:10.1101/2021.04.13.21255409

Gomaa, Elshoubaky, Antiviral Activity of Sulfated Polysaccharides Carrageenan from Some Marine Seaweeds, International Journal of Current Pharmaceutical Review and Research

Grassauer, Weinmuellner, Meier, Pretsch, Prieschl-Grassauer et al., Iota-Carrageenan is a potent inhibitor of rhinovirus infection, Virol J, doi:10.1186/1743-422x-5-107

Gubernatorova, Gorshkova, Polinova, Drutskaya, IL-6: relevance for immunopathology of SARS-CoV-2, Cytokine Growth F R, doi:10.1016/j.cytogfr.2020.05.009

Hans, Malik, Naik, Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: Mini review, Bioresour Technology Reports, doi:10.1016/j.biteb.2020.100623

Hoffmann, Mösbauer, Hofmann-Winkler, Kaul, Kleine-Weber et al., Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2, Nature, doi:10.1038/s41586-020-2575-3

Holwerda, V'kovski, Wider, Thiel, Dijkman, Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2

Koenighofer, Lion, Bodenteich, Prieschl-Grassauer, Grassauer et al., Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials, Multidiscip Resp Med, doi:10.1186/2049-6958-9-57

Leibbrandt, Meier, König-Schuster, Weinmüllner, Kalthoff et al., Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection, Plos One, doi:10.1371/journal.pone.0014320

Morokutti-Kurz, Graf, Grassauer, Prieschl-Grassauer, SARS-CoV-2 invitro neutralization assay reveals inhibition of virus entry by iota-carrageenan, Biorxiv, doi:10.1101/2020.07.28.224733

Morokutti-Kurz, König-Schuster, Koller, Graf, Graf et al., The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model, Plos One, doi:10.1371/journal.pone.0128794

Murgolo, Therien, Howell, Klein, Koeplinger et al., SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development, Plos Pathog, doi:10.1371/journal.ppat.1009225

Osada, Kohara, Yamaji, Hirayama, Kasai et al., The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line, Dna Res, doi:10.1093/dnares/dsu029

Park, Kim, Park, Maharjan, Kim et al., Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection, Biomol Ther, doi:10.4062/biomolther.2020.226

Saccon, Chen, Mikaeloff, Rodriguez, Szekely et al., Tropism of SARS-CoV-2 in commonly used laboratory cell lines and their proteomic landscape during infection, Biorxiv, doi:10.1101/2020.08.28.271684

Salgado-Benvindo, Thaler, Tas, Ogando, Bredenbeek et al., Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle, Antimicrob Agents Ch, doi:10.1128/aac.00900-20

Song, Peng, Wang, Liu, Dong et al., Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2, Food Funct, doi:10.1039/d0fo02017f

Yamamoto, Kiso, Sakai-Tagawa, Iwatsuki-Horimoto, Imai et al., The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner, Viruses, doi:10.3390/v12060629

Zhu, Chidekel, Shaffer, Cultured Human Airway Epithelial Cells (Calu-3): A Model of Human Respiratory Function, Structure, and Inflammatory Responses, Critical Care Res Pract, doi:10.1155/2010/394578

Zhu, Miller, Singhaus, Shaffer, Chidekel, Effects of oxygen concentration and exposure time on cultured human airway epithelial cells, Pediatr Crit Care Me, doi:10.1097/pcc.0b013e318166fbb5

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0